Showing results (1-10 of 50) with videos related to
Sort By:
Pageof 5
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 22, 2009
Safety of intravenous infusion of doripenemRebecca Redman, Thomas M FileExpert Opinion on Investigational Drugs|August 2, 2002
Iseganan HCl: a novel antimicrobial agentFrancis J Giles, Rebecca Redman, Salim Yazji, et al.International Journal of Antimicrobial Agents|February 16, 2013
Activity of doripenem versus comparators in subjects with baseline bacteraemia in six pooled phase 3 clinical trialsDennis A K Rice, Koné Kaniga, Michael Lee, et al.Antimicrobial Agents and Chemotherapy|January 5, 2011
Influence of continuous venovenous hemofiltration and continuous venovenous hemodiafiltration on the disposition of doripenemIolanda Cirillo, Nicole Vaccaro, Dainius Balis, et al.Drug Safety|August 13, 2009
Overview of seizure-inducing potential of doripenemGeorge G Zhanel, Nzeera Ketter, Ethan Rubinstein, et al.Medical Oncology (Northwood, London, England)|November 2, 2019
Correction to: Outcomes of hypercalcemia of malignancy in patients with solid cancer: a national inpatient analysisShruti Bhandari, Rohit Kumar, Prashant Tripathi, et al.Advances in Therapy|April 17, 2016
Exposure-Response Relationship for Ombitasvir and Paritaprevir/Ritonavir in Hepatitis C Virus Subgenotype 1b-Infected Japanese Patients in the Phase 3 Randomized GIFT-I StudySathej Gopalakrishnan, Amit Khatri, Sven Mensing, et al.Journal of Clinical Pharmacology|June 26, 2009
Pharmacokinetics, safety, and tolerability of doripenem after 0.5-, 1-, and 4-hour infusions in healthy volunteersIolanda Cirillo, Nicole Vaccaro, Kenneth Turner, et al.Journal of Clinical Pharmacology|December 17, 2011
Pharmacokinetics of single-dose doripenem in adults with cystic fibrosisIolanda Cirillo, Nicole Vaccaro, Rebecca Redman, et al.Medical Oncology (Northwood, London, England)|September 19, 2019
Outcomes of hypercalcemia of malignancy in patients with solid cancer: a national inpatient analysisShruti Bhandari, Rohit Kumar, Prashant Tripathi, et al.Pageof 5